N

Neon Therapeutics

16 employees

NEON Therapeutics is focused on unlocking the full potential of the immune system to recognize and attack cancer.

Basic info

Industry

biotechnology research

Sectors

Neoantigens
Cancer vaccines
Biotechnology
Health Care
T cell therapies
Immune monitoring
Therapeutics
Medical
Epitope selection
Bioinformatics

Date founded

2015

Funding rounds raised

Total raised

$70M

from 16 investors over 16 rounds

N

Neon Therapeutics raised $36M on December 5, 2017

Investors: Nextech Invest, Access Industries, Casdin Capital, LLC, Hillhouse Capital Management, Inbio Ventures, - and Wellington Management

N

Neon Therapeutics raised $70M on January 5, 2017

Investors: Access Industries, Nextech Invest, -, Third Rock Ventures, Wellington Management and Inbio Ventures

N

Neon Therapeutics raised $55M on October 1, 2015

Investors: Access Industries, Third Rock Ventures and Clal Biotechnology Industries

FAQ